Nipun B. Merchant

Nipun B. Merchant

Surgical Oncology
1475 Northwest 12th Avenue
Miami, FL 33136

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 185 publications

Oligometastatic GIST: Impact of Treatment Modalities and Metastatic Distribution on Overall Survival.

Oligometastatic GIST: Impact of Treatment Modalities and Metastatic Distribution on Overall Survival.

Journal: Cancers
Published: July 03, 2026

IL1RAP-expressing myeloid-stromal networks represent a therapeutic vulnerability to improve chemoimmunotherapy sensitivity in pancreatic cancer.

IL1RAP-expressing myeloid-stromal networks represent a therapeutic vulnerability to improve chemoimmunotherapy sensitivity in pancreatic cancer.

Journal: JCI insight
Published: June 22, 2026

ASO Visual Abstract: Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cancer.

ASO Visual Abstract: Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cancer.

Journal: Annals of surgical oncology
Published: December 18, 2025

Targeting CREB remodels the immune microenvironment to enhance immunotherapy responses in pancreatic cancer.

Targeting CREB remodels the immune microenvironment to enhance immunotherapy responses in pancreatic cancer.

Journal: bioRxiv : the preprint server for biology
Published: December 15, 2025

Knowledge-informed multimodal cfDNA analysis improves sensitivity and generalization in cancer detection.

Knowledge-informed multimodal cfDNA analysis improves sensitivity and generalization in cancer detection.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

Long-Term Surveillance and Management Recommendations for Intraductal Papillary Mucinous Neoplasms.

Long-Term Surveillance and Management Recommendations for Intraductal Papillary Mucinous Neoplasms.

Journal: Advances in surgery
Published: August 06, 2025

Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cancer.

Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cancer.

Journal: Annals of surgical oncology
Published: July 25, 2025

CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Alcoholic Pancreatitis.

CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Alcoholic Pancreatitis.

Journal: Cellular and molecular gastroenterology and hepatology
Published: June 12, 2025

SMAD4 Alterations are a Predictive Biomarker to Guide First-line Chemotherapy Selection for the Neoadjuvant Treatment of Localized Pancreatic Cancer : A Multicenter, Retrospective Cohort Study.

SMAD4 Alterations are a Predictive Biomarker to Guide First-line Chemotherapy Selection for the Neoadjuvant Treatment of Localized Pancreatic Cancer : A Multicenter, Retrospective Cohort Study.

Journal: Annals of surgery
Published: June 05, 2025

Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuvant therapy in pancreatic cancer.

Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuvant therapy in pancreatic cancer.

Journal: Cancer
Published: April 15, 2025

Editor's Note: Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.

Editor's Note: Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.

Journal: Cancer research
Published: March 21, 2025

Somatic Genomic Profiling of Pancreatic Ductal Adenocarcinomas From a Diverse Cohort of Patients.

Somatic Genomic Profiling of Pancreatic Ductal Adenocarcinomas From a Diverse Cohort of Patients.

Journal: Pancreas
Published: February 25, 2025
Showing 1-12 of 185

Last Updated: 09/26/2026